Skip to content
$
0.00
0
Cart
Search
(780) 448-0585
IOT.V 0.25 0.00 0.00%
Services
By Application
Anti-Adherence
Anti-Encrustation Testing
Antimicrobials
Environmental Bioburden Monitoring
Facility Water Testing
GMP Analytical Chemistry Testing Services
Medical Device Testing
MIC, MBC, MFC, Toxicology Testing
Microbiology Testing Services
Pharmaceutical & Drug Development
Stability Testing Services
Sterility Testing
By Method
Antimicrobial Effectiveness Testing USP <51>
BEST Assay™ Method
Environmental Bioburden Monitoring
GMP Analytical Chemistry Testing Services
MBEC Assay® Testing
Method Development and Validation Services
MIC, MBC, MFC, Toxicology Testing
By Industry
Compounding Pharmacies
Medical Device Testing
Pharmaceutical & Drug Development
Products
MBEC
InnovoSIL
Resources
Investor Relations
Company
Our Team / History
Careers
Quality
Contact
Contact Us
Annual and Interim Financial Statements
September 30, 2022
Interim Financial Statements & MD&A for period ended 30 Sept 2022
June 30, 2022
Interim Financial Statements & MD&A for period ended 30 June 2022
March 31, 2022
Interim Financial Statements & MD&A for period ended 31 March 2022
December 31, 2021
Annual Financial Statements & MD&A For the 2021 year ended December 31
September 30, 2021
Interim Financial Statements & MD&A for period ended 30 September 2021
June 30, 2021
Interim Financial Statements & MD&A for period ended 30 June 2021
March 31, 2021
Interim Financial Statements & MD&A for period ended 31 March 2021
December 31, 2020
Annual Financial Statements & MD&A For the 2020 year ended December 31
September 30, 2020
Interim Financial Statements for the three and nine months ended September 30th 2020
June 30, 2020
Interim Financial Statements (Unaudited) For the three and six-month periods ended June 30, 2020 and 2019
December 31, 2019
Annual Financial Statements & MD&A For the 2019 year ended December 31
September 30, 2019
2019, Q3, 2019, For the three and nine-month periods ended September 30, 2019 and 2018
Page
1
Page
2
Page
3
